CSCO 2025 | Professor Ma Jun: 120 Years of Chinese Hematology Establishing a Global Benchmark – CSCO Annual Meeting to Decode Innovative Therapies and Cutting-Edge Breakthroughs
The 28th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) will be held in Jinan, Shandong, from September 10–14, 2025. This year’s meeting, themed “Standardized Diagnosis and Treatment,…
CSCO Experts’ Voice | Professor Jianming Guo: Outlook on the Development of China’s Prostate Cancer MDT Model and the Future of AI Applications
Editor’s Note: This September, the 28th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO 2025), one of China’s most prestigious oncology conferences, was successfully held in Jinan. During…
2025 COMB丨Professor Fei Ma: New Perspectives in Breast Cancer Immunotherapy—Mechanistic Insights, Adverse Event Management, and Precision Pathways
Editor’s Note: Immunotherapy has become an important treatment modality in breast cancer, achieving breakthroughs by modulating the immune system to mount anti-tumor responses. At the 8th Conference on Oncology Precision…
Professor Bing Han: Treatment Strategies for Aplastic Anemia in the TPO-RA Era
Editor’s Note: The 13th Ludaopei Hematology Academic Conference, jointly organized by the Beijing Health Promotion Association and the Hongmian Tumor and Rare Disease Public Welfare Foundation, and hosted by the…
Academician Xishan Hao: The Mission of Advancing Chinese Oncology and Building Academic Journal
Editor’s Note: With China’s rapidly aging population, cancer prevention and treatment face new challenges and opportunities. As the birthplace of modern oncology in China, Tianjin Medical University Cancer Institute and…